{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:36Z","timestamp":1786119336379,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/cad.0b013e32831845e1","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T03:18:29Z","timestamp":1226978309000},"page":"51-58","source":"Crossref","is-referenced-by-count":9,"title":["Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models"],"prefix":"10.1097","volume":"20","author":[{"given":"Pasi T.","family":"Pennanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna S.","family":"Sarvilinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo J.","family":"Ylikomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0959-8049(96)00032-9","article-title":"New endocrine therapies for breast cancer","volume":"32A","author":"Howell","year":"1996","journal-title":"Eur J Cancer"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/erc.1.00594","article-title":"A review of adjuvant hormonal therapy in breast cancer","volume":"11","author":"Jones","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/er.2003-0010","article-title":"Estrogen receptor mutations in human disease","volume":"25","author":"Herynk","year":"2004","journal-title":"Endocr Rev"},{"key":"R4-7-20210203","first-page":"3331","article-title":"Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer","volume":"55","author":"Johnston","year":"1995","journal-title":"Cancer Res"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jnci\/95.5.353","article-title":"Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2\/neu in tamoxifen resistance in breast cancer","volume":"95","author":"Osborne","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00665801","article-title":"Measurement of steroid hormone receptors in breast cancer patients on tamoxifen","volume":"26","author":"Encarnacion","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"R7-7-20210203","first-page":"5421","article-title":"Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients","volume":"59","author":"Speirs","year":"1999","journal-title":"Cancer Res"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1073\/pnas.95.6.2920","article-title":"Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes","volume":"95","author":"Lavinsky","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-7-20210203","first-page":"1259","article-title":"Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen","volume":"9","author":"Girault","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1005903226483","article-title":"Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer","volume":"48","author":"Berns","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2005.01.172","article-title":"Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase","volume":"23","author":"Gutierrez","year":"2005","journal-title":"J Clin Oncol"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/path.1829","article-title":"AKT activation predicts outcome in breast cancer patients treated with tamoxifen","volume":"207","author":"Kirkegaard","year":"2005","journal-title":"J Pathol"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1158\/1078-0432.CCR-04-0110","article-title":"HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study","volume":"10","author":"Arpino","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:BREA.0000041623.21338.47","article-title":"Increased constitutive activity of PKB\/Akt in tamoxifen resistant breast cancer MCF-7 cells","volume":"87","author":"Jordan","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1210\/en.2002-220620","article-title":"Elevated levels of epidermal growth factor receptor\/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells","volume":"144","author":"Knowlden","year":"2003","journal-title":"Endocrinology"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/endo.142.7.8259","article-title":"Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182\u2009780 (Faslodex)","volume":"142","author":"McClelland","year":"2001","journal-title":"Endocrinology"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/djh166","article-title":"Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2\/neu cross-talk in ER\/HER2-positive breast cancer","volume":"96","author":"Shou","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R18-7-20210203","first-page":"557","article-title":"Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitro","volume":"31","author":"Scott","year":"2007","journal-title":"Int J Oncol"},{"key":"R19-7-20210203","first-page":"4130","article-title":"Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling","volume":"60","author":"Badia","year":"2000","journal-title":"Cancer Res"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0960-0760(96)00114-8","article-title":"Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen","volume":"59","author":"Herman","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.10252","article-title":"Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade","volume":"98","author":"Rabenoelina","year":"2002","journal-title":"Int J Cancer"},{"key":"R22-7-20210203","first-page":"3229","article-title":"MCF7\/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182\u2009780","volume":"53","author":"Brunner","year":"1993","journal-title":"Cancer Res"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ijc.2910610417","article-title":"Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment","volume":"61","author":"Lykkesfeldt","year":"1995","journal-title":"Int J Cancer"},{"key":"R24-7-20210203","first-page":"1587","article-title":"Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164\u2009384 and ICI 182\u2009780 sensitive human breast cancer cell line, MCF-7\/TAMR-1","volume":"54","author":"Lykkesfeldt","year":"1994","journal-title":"Cancer Res"},{"key":"R25-7-20210203","first-page":"3486","article-title":"MCF7\/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182\u2009780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen","volume":"57","author":"Brunner","year":"1997","journal-title":"Cancer Res"},{"key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsbmb.2005.11.005","article-title":"Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182\u2009780) in MCF7 human breast cancer cells","volume":"99","author":"Shaw","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R27-7-20210203","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1677\/erc.1.00905","article-title":"The anti-oestrogen ICI 182\u2009780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling","volume":"12","author":"Martin","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.21431","article-title":"Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells","volume":"118","author":"Sarvilinna","year":"2006","journal-title":"Int J Cancer"},{"key":"R29-7-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0960-0760(03)00366-2","article-title":"Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways","volume":"86","author":"Yue","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R30-7-20210203","first-page":"283","article-title":"Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications","volume":"53","author":"Brunner","year":"1993","journal-title":"Cancer Res"},{"key":"R31-7-20210203","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1073\/pnas.86.10.3649","article-title":"Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo","volume":"86","author":"Clarke","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-7-20210203","first-page":"2918","article-title":"Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells","volume":"80","author":"Masamura","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-7-20210203","doi-asserted-by":"crossref","first-page":"30458","DOI":"10.1074\/jbc.M305226200","article-title":"Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation","volume":"278","author":"Martin","year":"2003","journal-title":"J Biol Chem"},{"key":"R34-7-20210203","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"R35-7-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1025952924864","article-title":"Progesterone receptors in mammary gland development and tumorigenesis","volume":"8","author":"Conneely","year":"2003","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R36-7-20210203","first-page":"3428","article-title":"Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182\u2009780)","volume":"62","author":"Gu","year":"2002","journal-title":"Cancer Res"},{"key":"R37-7-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-005-5776-4","article-title":"Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells","volume":"94","author":"Santen","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R38-7-20210203","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00001813-200409000-00008","article-title":"Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells","volume":"15","author":"Treeck","year":"2004","journal-title":"Anti-Cancer Drugs"},{"key":"R39-7-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1677\/erc.0.0100409","article-title":"Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens","volume":"10","author":"De Cremoux","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"R40-7-20210203","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1128\/MCB.18.12.7095","article-title":"Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells","volume":"18","author":"Kustikova","year":"1998","journal-title":"Mol Cell Biol"},{"key":"R41-7-20210203","first-page":"5168","article-title":"Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells","volume":"61","author":"Zajchowski","year":"2001","journal-title":"Cancer Res"},{"key":"R42-7-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/B:BREA.0000032982.49024.71","article-title":"The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas","volume":"86","author":"Milde-Langosch","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"R43-7-20210203","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.onc.1208312","article-title":"FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells","volume":"24","author":"Belguise","year":"2005","journal-title":"Oncogene"},{"key":"R44-7-20210203","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1074\/jbc.M010840200","article-title":"Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance","volume":"276","author":"Campbell","year":"2001","journal-title":"J Biol Chem"},{"key":"R45-7-20210203","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/carcin\/bgi031","article-title":"The macrophage inhibitory cytokine integrates AKT\/PKB and MAP kinase signaling pathways in breast cancer cells","volume":"26","author":"Wollmann","year":"2005","journal-title":"Carcinogenesis"},{"key":"R46-7-20210203","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.1158\/0008-5472.CAN-06-2106","article-title":"Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells","volume":"66","author":"Shtutman","year":"2006","journal-title":"Cancer Res"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32831845e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:03:26Z","timestamp":1786039406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200901000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32831845e1","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}